BVDV: A pestivirus inducing tolerance of the innate immune response

Biologicals

Volumn 41, Issue 1, 2013, Pages 39-51

  Peterhans, Ernst ^a   Schweizer, Matthias ^a  

^a University of Bern Institute of Veterinary Virology   (Switzerland)

Author keywords

Co evolution; Innate immunotolerance; Interferon; Pestivirus; Self nonself discrimination; Viral RNase

Indexed keywords

ALPHA INTERFERON; INTERFERON; INTERFERON REGULATORY FACTOR 3; N TERMINAL AUTOPROTEASE; PATTERN RECOGNITION RECEPTOR; PROTEIN ERNS; RECEPTOR; RIBONUCLEASE; RIG 1 LIKE RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; BOVINE DIARRHEA VIRUS; BOVINE VIRAL DIARRHEA; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME ACTIVITY; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE EVASION; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INNATE IMMUNITY; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; VIRUS IMMUNITY; VIRUS SURVIVAL; VIRUS VIRULENCE;

ADAPTIVE IMMUNITY; ANIMALS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUSES, BOVINE VIRAL; ENDORIBONUCLEASES; HOST-PATHOGEN INTERACTIONS; IMMUNE EVASION; IMMUNE TOLERANCE; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERONS; MODELS, IMMUNOLOGICAL; VIRAL PROTEINS;

ANIMALIA; BOVINE VIRAL DIARRHEA VIRUS 1; PESTIVIRUS;

EID: 84872144604     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2012.07.006     Document Type: Article

References (261)

1. Butler D. Portrait of a year-old pandemic. Nature 2010, 464:1112-1113.
2. Alcamí A., Koszinowski U.H. Viral mechanisms of immune evasion. Immunol Today 2000, 21:447-455.
3. Finlay B.B., McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 2006, 124:767-782.
4. Bowie A.G., Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 2008, 8:911-922.
5. Gerlier D., Lyles D.S. Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol Mol Biol Rev 2011, 75:468-490.
6. Jiang X.M., Chen Z.J.J. The role of ubiquitylation in immune defence and pathogen evasion. Nat Rev Immunol 2012, 12:35-48.
7. Vivier E., Malissen B. Innate and adaptive immunity: specificities and signaling hierarchies revisited. Nat Immunol 2005, 6:17-21.
8. Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295.
9. Villarreal L.P. Persistence pays: how viruses promote host group survival. Curr Opin Microbiol 2009, 12:467-472.
10. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
11. Vance R.E., Isberg R.R., Portnoy D.A. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 2009, 6:10-21.
12. Lemaitre B. The road to Toll. Nat Rev Immunol 2004, 4:521-527.
13. Mogensen T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009, 22:240-273.
14. Kumagai Y., Akira S. Identification and functions of pattern-recognition receptors. J Allergy Clin Immunol 2010, 125:985-992.
15. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
16. Wilkins C., Gale M. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 2010, 22:41-47.
17. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009, 27:229-265.
18. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
19. Meylan E., Tschopp J., Karin M. Intracellular pattern recognition receptors in the host response. Nature 2006, 442:39-44.
20. Weber F., Wagner V., Rasmussen S.B., Hartmann R., Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 2006, 80:5059-5064.
21. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
22. Dostert C., Meylan E., Tschopp J. Intracellular pattern-recognition receptors. Adv Drug Deliv Rev 2008, 60:830-840.
23. Ishii K.J., Koyama S., Nakagawa A., Coban C., Akira S. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 2008, 3:352-363.
24. Baccala R., Gonzalez-Quintial R., Lawson B.R., Stern M.E., Kono D.H., Beutler B., et al. Sensors of the innate immune system: their mode of action. Nat Rev Rheumatol 2009, 5:448-456.
25. Kumar H., Kawai T., Akira S. Pathogen recognition in the innate immune response. Biochem J 2009, 420:1-16.
26. Rathinam V.A., Fitzgerald K.A. Cytosolic surveillance and antiviral immunity. Curr Opin Virol 2011, 1:455-462.
27. Kerur N., Veettil M.V., Sharma-Walia N., Bottero V., Sadagopan S., Otageri P., et al. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-associated herpesvirus infection. Cell Host Microbe 2011, 9:363-375.
28. Roach J.C., Glusman G., Rowen L., Kaur A., Purcell M.K., Smith K.D., et al. The evolution of vertebrate toll-like receptors. Proc Natl Acad Sci U S A 2005, 102:9577-9582.
29. Rasmussen S.B., Reinert L.S., Paludan S.R. Innate recognition of intracellular pathogens: detection and activation of the first line of defense. APMIS 2009, 117:323-337.
30. Hansen J.D., Vojtech L.N., Laing K.J. Sensing disease and danger: a survey of vertebrate PRRs and their origins. Dev Comp Immunol 2011, 35:886-897.
31. Star B., Nederbragt A.J., Jentoft S., Grimholt U., Malmstrøm M., Gregers T.F., et al. The genome sequence of Atlantic cod reveals a unique immune system. Nature 2011, 477:207-210.
32. Beutler B., Jiang Z.F., Georgel P., Crozat K., Croker B., Rutschmann S., et al. Genetic analysis of host resistance: toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006, 24:353-389.
33. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995.
34. Vercammen E., Staal J., Beyaert R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 2008, 21:13-25.
35. Ishii K.J., Akira S. TLR ignores methylated RNA?. Immunity 2005, 23:111-113.
36. Karikó K., Buckstein M., Ni H.P., Weissman D. Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005, 23:165-175.
37. Bauer S. Toll-erating self DNA. Nat Immunol 2006, 7:13-15.
38. Deane J.A., Pisitkun P., Barrett R.S., Feigenbaum L., Town T., Ward J.M., et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 2007, 27:801-810.
39. Krieg A.M. The toll of too much TLR7. Immunity 2007, 27:695-697.
40. Deane J.A., Bolland S. Nucleic acid-sensing TLRs as modifiers of autoimmunity. J Immunol 2006, 177:6573-6578.
41. Baccala R., Hoebe K., Kono D.H., Beutler B., Theofilopoulos A.N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 2007, 13:543-551.
42. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat Rev Immunol 2008, 8:279-289.
43. Theofilopoulos A.N., Kono D.H., Beutler B., Baccala R. Intracellular nucleic acid sensors and autoimmunity. J Interferon Cytokine Res 2011, 31:867-886.
44. Pichlmair A., Sousa C.R.E. Innate recognition of viruses. Immunity 2007, 27:370-383.
45. Diebold S. Innate recognition of viruses. Immunol Lett 2010, 128:17-20.
46. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001, 413:732-738.
47. Majde J.A. Viral double-stranded RNA, cytokines, and the flu. J Interferon Cytokine Res 2000, 20:259-272.
48. DeWitte-Orr S.J., Mossman K.L. dsRNA and the innate antiviral immune response. Future Virol 2010, 5:325-341.
49. Karikó K., Bhuyan P., Capodici J., Weissman D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J Immunol 2004, 172:6545-6549.
50. Marques J.T., Devosse T., Wang D., Zamanian-Daryoush M., Serbinowski P., Hartmann R., et al. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 2006, 24:559-565.
51. Reynolds A., Anderson E.M., Vermeulen A., Fedorov Y., Robinson K., Leake D., et al. Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA 2006, 12:988-993.
52. Kleinman M.E., Yamada K., Takeda A., Chandrasekaran V., Nozaki M., Baffi J.Z., et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 2008, 452:591-597.
53. Pirher N., Ivičak K., Pohar J., Benčina M., Jerala R. A second binding site for double-stranded RNA in TLR3 and consequences for interferon activation. Nat Struct Mol Biol 2008, 15:761-763.
54. Diebold S.S., Kaisho T., Hemmi H., Akira S., Sousa C.R.E. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
55. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
56. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams N.C., Gale N.W., et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 2004, 101:5598-5603.
57. Liu J., Xu C.F., Hsu L.C., Luo Y.P., Xiang R., Chuang T.H. A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition. Mol Immunol 2010, 47:1083-1090.
58. Martinez J., Huang X.P., Yang Y.P. Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNA. Proc Natl Acad Sci U S A 2010, 107:6442-6447.
59. Limmon G.V., Arredouani M., McCann K.L., Minor R.A.C., Kobzik L., Imani F. Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA. FASEB J 2008, 22:159-167.
60. DeWitte-Orr S.J., Collins S.E., Bauer C.M.T., Bowdish D.M., Mossman K.L. An accessory to the 'Trinity': SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses. PLoS Pathog 2010, 6:e1000829.
61. Andrejeva J., Childs K.S., Young D.F., Carlos T.S., Stock N., Goodbourn S., et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 2004, 101:17264-17269.
62. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5:730-737.
63. Schmidt A., Rothenfusser S., Hopfner K.P. Sensing of viral nucleic acids by RIG-I: from translocation to translation. Eur J Cell Biol 2012, 91:78-85.
64. Gitlin L., Barchet W., Gilfillan S., Cella M., Beutler B., Flavell R.A., et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 2006, 103:8459-8464.
65. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008, 205:1601-1610.
66. Pichlmair A., Schulz O., Tan C.P., Rehwinkel J., Kato H., Takeuchi O., et al. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 2009, 83:10761-10769.
67. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., et al. 5'-triphosphate RNA is the ligand for RIG-I. Science 2006, 314:994-997.
68. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljeström P., Weber F., et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314:997-1001.
69. Myong S., Cui S., Cornish P.V., Kirchhofer A., Gack M.U., Jung J.U., et al. Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent translocase on double-stranded RNA. Science 2009, 323:1070-1074.
70. Schlee M., Roth A., Hornung V., Hagmann C.A., Wimmenauer V., Barchet W., et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009, 31:25-34.
71. Schmidt A., Schwerd T., Hamm W., Hellmuth J.C., Cui S., Wenzel M., et al. 5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci U S A 2009, 106:12067-12072.
72. Wang Y.L., Ludwig J., Schuberth C., Goldeck M., Schlee M., Li H.T., et al. Structural and functional insights into 5'-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat Struct Mol Biol 2010, 17:781-787.
73. O'Neill L.A.J., Bowie A.G. The powerstroke and camshaft of the RIG-I antiviral RNA detection machine. Cell 2011, 147:259-261.
74. Jiang F.G., Ramanathan A., Miller M.T., Tang G.Q., Gale M., Patel S.S., et al. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 2011, 479:423-427.
75. Decroly E., Ferron F., Lescar J., Canard B. Conventional and unconventional mechanisms for capping viral mRNA. Nat Rev Microbiol 2012, 10:51-65.
76. Rothenfusser S., Goutagny N., Diperna G., Gong M., Monks B.G., Schoenemeyer A., et al. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol 2005, 175:5260-5268.
77. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005, 175:2851-2858.
78. Saito T., Hirai R., Loo Y.M., Owen D., Johnson C.L., Sinha S.C., et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A 2007, 104:582-587.
79. Moresco E.M.Y., Beutler B. LGP2: positive about viral sensing. Proc Natl Acad Sci U S A 2010, 107:1261-1262.
80. Satoh T., Kato H., Kumagai Y., Yoneyama M., Sato S., Matsushita K., et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A 2010, 107:1512-1517.
81. Seth R.B., Sun L.J., Ea C.K., Chen Z.J.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 2005, 122:669-682.
82. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005, 6:981-988.
83. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z.H., Shu H.B. VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol Cell 2005, 19:727-740.
84. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
85. Dixit E., Boulant S., Zhang Y.J., Lee A.S.Y., Odendall C., Shum B., et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 2010, 141:668-681.
86. Sharma S., Fitzgerald K.A. Viral defense: it takes two MAVS to tango. Cell 2010, 141:570-572.
87. Castanier C., Garcin D., Vazquez A., Arnoult D. Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway. EMBO Rep 2010, 11:133-138.
88. Onoguchi K., Onomoto K., Takamatsu S., Jogi M., Takemura A., Morimoto S., et al. Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog 2010, 6:e1001012.
89. Hou F.J., Sun L.J., Zheng H., Skaug B., Jiang Q.X., Chen Z.J.J. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146:448-461.
90. Lee M.S., Kim Y.-J. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 2007, 76:447-480.
91. Komuro A., Bamming D., Horvath C.M. Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine 2008, 43:350-358.
92. O'Neill L.A.J. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 2008, 29:12-20.
93. Bennett E.J., Harper J.W. Ubiquitin gets CARDed. Cell 2010, 141:220-222.
94. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 2010, 11:373-384.
95. Richards K.H., Macdonald A. Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) production. Microbes Infect 2011, 13:291-302.
96. Eisenächer K., Krug A. Regulation of RLR-mediated innate immune signaling - it is all about keeping the balance. Eur J Cell Biol 2012, 91:36-47.
97. Oshiumi H., Matsumoto M., Seya T. Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I. J Biochem (Tokyo) 2012, 151:5-11.
98. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
99. Takeuchi O., Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008, 20:17-22.
100. Muñoz-Jordán J.L., Fredericksen B.L. How flaviviruses activate and suppress the interferon response. Viruses 2010, 2:676-691.
101. Blasius A.L., Beutler B. Intracellular toll-like receptors. Immunity 2010, 32:305-315.
102. Lin S.C., Lo Y.C., Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 2010, 465:885-890.
103. Wasserman S.A. Immunity takes a heavy toll. Nature 2010, 465:882-883.
104. Kawai T., Akira S. Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins. EMBO Mol Med 2011, 3:513-527.
105. Barton G.M., Kagan J.C. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol 2009, 9:535-542.
106. McGettrick A.F., O'Neill L.A.J. Localisation and trafficking of toll-like receptors: an important mode of regulation. Curr Opin Immunol 2010, 22:20-27.
107. Marek L.R., Kagan J.C. Deciphering the function of nucleic acid sensing TLRs one regulatory step at a time. Front Biosci - Landmark 2011, 16:2060-2068.
108. Manoury B. TLR9 regulation by proteolysis: a friend or a foe. Eur J Immunol 2011, 41:2142-2144.
109. Kagan J.C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat Immunol 2008, 9:361-368.
110. Jacobs B.L., Langland J.O. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 1996, 219:339-349.
111. Samuel C.E. Antiviral actions of interferons. Clin Microbiol Rev 2001, 14:778-809.
112. Stetson D.B., Medzhitov R. Type I interferons in host defense. Immunity 2006, 25:373-381.
113. Isaacs A., Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957, 147:258-267.
114. Lindenmann J. Interferon and before. J Interferon Cytokine Res 2007, 27:3-5.
115. Lindenmann J. 50 years ago: how prepared were our minds?. Biochimie 2007, 89:719-720.
116. Lindenmann J. How to chase a red herring and come up with a smallmouth bass. Interferon: the 50th anniversary 2007, 3-7. Springer Verlag, Berlin. P.M. Pitha (Ed.).
117. Editorial Hope to end viral disease. Sci News 1967, 92:173-174.
118. Pestka S., Krause C.D., Walter M.R. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004, 202:8-32.
119. Ank N., Paludan S.R. Type III IFNs: new layers of complexity in innate antiviral immunity. Biofactors 2009, 35:82-87.
120. Kotenko S.V. IFN-λs. Curr Opin Immunol 2011, 23:583-590.
121. Panne D. The enhanceosome. Curr Opin Struct Biol 2008, 18:236-242.
122. Honda K., Taniguchi T. IRFs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006, 6:644-658.
123. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008, 89:1-47.
124. Balachandran S., Beg A.A. Defining emerging roles for NF-κB in antivirus responses: revisiting the interferon-β enhanceosome paradigm. PLoS Pathog 2011, 7:e1002165.
125. Izaguirre A., Barnes B.J., Amrute S., Yeow W.S., Megjugorac N., Dai J.H., et al. Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J Leukoc Biol 2003, 74:1125-1138.
126. Coccia E.M., Severa M., Giacomini E., Monneron D., Remoli M.E., Julkunen I., et al. Viral infection and toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 2004, 34:796-805.
127. Colina R., Costa-Mattioli M., Dowling R.J.O., Jaramillo M., Tai L.H., Breitbach C.J., et al. Translational control of the innate immune response through IRF-7. Nature 2008, 452:323-328.
128. Der S.D., Zhou A.M., Williams B.R.G., Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 1998, 95:15623-15628.
129. Hertzog P., Forster S., Samarajiwa S. Systems biology of interferon responses. J Interferon Cytokine Res 2011, 31:5-11.
130. Samuel C.E. Interferons, interferon receptors, signal transducer and transcriptional activators, and interferon regulatory factors. J Biol Chem 2007, 282:20045-20046.
131. Shuai K., Liu B. Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 2003, 3:900-911.
132. Galligan C.L., Murooka T.T., Rahbar R., Baig E., Majchrzak-Kita B., Fish E.N. Interferons and viruses - signaling for supremacy. Immunol Res 2006, 35:27-39.
133. Takaoka A., Yanai H. Interferon signalling network in innate defence. Cell Microbiol 2006, 8:907-922.
134. Haller O., Kochs G., Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344:119-130.
135. Borden E.C., Sen G.C., Uze G., Silverman R.H., Ransohoff R.M., Foster G.R., et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 2007, 6:975-990.
136. Schoggins J.W., Rice C.M. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 2011, 1:519-525.
137. Sadler A.J., Williams B.R.G. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008, 8:559-568.
138. Von Wussow P., Jakschies D., Hochkeppel H.-K., Fibich C., Penner L., Deicher H. The human intracellular Mx-homologous protein is specifically induced by type I interferons. Eur J Immunol 1990, 20:2015-2019.
139. Meager A., Visvalingam K., Dilger P., Bryan D., Wadhwa M. Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 2005, 31:109-118.
140. Holzinger D., Jorns C., Stertz S., Boisson-Dupuis S., Thimme R., Weidmann M., et al. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol 2007, 81:7776-7785.
141. Müller-Doblies D., Ackermann M., Metzler A. In vitro and in vivo detection of Mx gene products in bovine cells following stimulation with alpha/beta interferon and viruses. Clin Diagn Lab Immunol 2002, 9:1192-1199.
142. Schweizer M., Mätzener P., Pfaffen G., Stalder H.P., Peterhans E. " Self" and " nonself" manipulation of interferon defense during persistent infection: bovine viral diarrhea virus resists alpha/beta interferon without blocking antiviral activity against unrelated viruses replicating in its host cells. J Virol 2006, 80:6926-6935.
143. Haller O., Stertz S., Kochs G. The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect 2007, 9:1636-1643.
144. Horisberger M.A., Gunst M.C. Interferon-induced proteins: identification of Mx proteins in various mammalian species. Virology 1991, 180:185-190.
145. Yamada K., Nakatsu Y., Onogi A., Ueda J., Watanabe T. Specific intracellular localization and antiviral property of genetic and splicing variants in bovine Mx1. Viral Immunol 2009, 22:389-395.
146. Malathi K., Dong B.H., Gale M., Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007, 448:816-819.
147. Goodbourn S., Didcock L., Randall R.E. Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures. J Gen Virol 2000, 81:2341-2364.
148. Sen G.C. Viruses and interferons. Annu Rev Microbiol 2001, 55:255-281.
149. Bonjardim C.A. Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses - and viruses counteract IFN action. Microbes Infect 2005, 7:569-578.
150. Hengel H., Koszinowski U.H., Conzelmann K.K. Viruses know it all: new insights into IFN networks. Trends Immunol 2005, 26:396-401.
151. García-Sastre A., Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in détente. Science 2006, 312:879-882.
152. McInerney G.M., Hedestam G.B.K. Direct cleavage, proteasomal degradation and sequestration: three mechanisms of viral subversion of type I interferon responses. J Innate Immun 2009, 1:599-606.
153. Versteeg G.A., García-Sastre A. Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 2010, 13:508-516.
154. Diamond M.S. Mechanisms of evasion of the type I interferon antiviral response by flaviviruses. J Interferon Cytokine Res 2009, 29:521-530.
155. Horner S.M., Gale M. Intracellular innate immune cascades and interferon defenses that control hepatitis C virus. J Interferon Cytokine Res 2009, 29:489-498.
156. Li X.D., Sun L.J., Seth R.B., Pineda G., Chen Z.J.J. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 2005, 102:17717-17722.
157. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C.M., Ikeda M., et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 2005, 102:2992-2997.
158. Gale M., Foy E.M. Evasion of intracellular host defence by hepatitis C virus. Nature 2005, 436:939-945.
159. Saito T., Gale M. Regulation of innate immunity against hepatitis C virus infection. Hepatol Res 2008, 38:115-122.
160. Katze M.G., Fornek J.L., Palermo R.E., Walters K.A., Korth M.J. Innate immune modulation by RNA viruses: emerging insights from functional genomics. Nat Rev Immunol 2008, 8:644-654.
161. Takahashi K., Asabe S., Wieland S., Garaigorta U., Gastaminza P., Isogawa M., et al. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci U S A 2010, 107:7431-7436.
162. Sagan S.M., Sarnow P. Plasmacytoid dendritic cells as guardians in hepatitis C virus-infected liver. Proc Natl Acad Sci U S A 2010, 107:7625-7626.
163. Brownlie J. Pathogenesis of mucosal disease and molecular aspects of bovine virus diarrhoea virus. Vet Microbiol 1990, 23:371-382.
164. Peterhans E., Jungi T.W., Schweizer M. BVDV and innate immunity. Biologicals 2003, 31:107-111.
165. Neill J.D., Ridpath J.F. Gene expression changes in MDBK cells infected with genotype 2 bovine viral diarrhoea virus. Vet Microbiol 2003, 96:301-312.
166. Risatti G.R., Pomp D., Donis R.O. Patterns of cellular gene expression in cells infected with cytopathic or non-cytopathic bovine viral diarrhea virus. Anim Biotechnol 2003, 14:31-49.
167. Werling D., Ruryk A., Heaney J., Moeller E., Brownlie J. Ability to differentiate between cp and ncp BVDV by microarrays: towards an application in clinical veterinary medicine?. Vet Immunol Immunopathol 2005, 108:157-164.
168. Neill J.D., Ridpath J.F., Liebler-Tenorio E. Global gene expression profiling of bovine immature B cells using serial analysis of gene expression. Anim Biotechnol 2006, 17:21-31.
169. Borca M.V., Gudmundsdottir I., Fernández-Sainz I.J., Holinka L.G., Risatti G.R. Patterns of cellular gene expression in swine macrophages infected with highly virulent classical swine fever virus strain Brescia. Virus Res 2008, 138:89-96.
170. Neill J.D., Ridpath J.F. Increase in proto-oncogene mRNA transcript levels in bovine lymphoid cells infected with a cytopathic type 2 bovine viral diarrhea virus. Virus Res 2008, 135:326-331.
171. Durand S.V.M., Hulst M.M., De Wit A.A.C., Mastebroek L., Loeffen W.L.A. Activation and modulation of antiviral and apoptotic genes in pigs infected with classical swine fever viruses of high, moderate or low virulence. Arch Virol 2009, 154:1417-1431.
172. Lee S.R., Nanduri B., Pharr G.T., Stokes J.V., Pinchuk L.M. Bovine Viral Diarrhea Virus infection affects the expression of proteins related to professional antigen presentation in bovine monocytes. Biochim Biophys Acta 2009, 1794:14-22.
173. Shi Z.X., Sun J.F., Guo H.C., Tu C.C. Genomic expression profiling of peripheral blood leukocytes of pigs infected with highly virulent classical swine fever virus strain Shimen. J Gen Virol 2009, 90:1670-1680.
174. Smirnova N.P., Ptitsyn A.A., Austin K.J., Bielefeldt-Ohmann H., Van Campen H., Han H., et al. Persistent fetal infection with bovine viral diarrhea virus differentially affects maternal blood cell signal transduction pathways. Physiol Genomics 2009, 36:129-139.
175. Yamane D., Zahoor M.A., Mohamed Y.M., Azab W., Kato K., Tohya Y., et al. Microarray analysis reveals distinct signaling pathways transcriptionally activated by infection with bovine viral diarrhea virus in different cell types. Virus Res 2009, 142:188-199.
176. Li J., Yu Y.J., Feng L., Cai X.B., Tang H.B., Sun S.K., et al. Global transcriptional profiles in peripheral blood mononuclear cell during classical swine fever virus infection. Virus Res 2010, 148:60-70.
177. Adler B., Adler H., Pfister H., Jungi T.W., Peterhans E. Macrophages infected with cytopathic bovine viral diarrhea virus release a factor(s) capable of priming uninfected macrophages for activation-induced apoptosis. J Virol 1997, 71:3255-3258.
178. Schweizer M., Peterhans E. Oxidative stress in cells infected with bovine viral diarrhoea virus: a crucial step in the induction of apoptosis. J Gen Virol 1999, 80:1147-1155.
179. Perler L., Schweizer M., Jungi T.W., Peterhans E. Bovine viral diarrhoea virus and bovine herpesvirus-1 prime uninfected macrophages for lipopolysaccharide-triggered apoptosis by interferon-dependent and -independent pathways. J Gen Virol 2000, 81:881-887.
180. Schweizer M., Peterhans E. Noncytopathic bovine viral diarrhea virus inhibits double-stranded RNA-induced apoptosis and interferon synthesis. J Virol 2001, 75:4692-4698.
181. Bielefeldt Ohmann H., Rønsholt L., Bloch B. Demonstration of bovine viral diarrhoea virus in peripheral blood mononuclear cells of persistently infected, clinically normal cattle. J Gen Virol 1987, 68:1971-1982.
182. Peek S.F., Bonds M.D., Schaele P., Weber S., Friedrichs K., Schultz R.D. Evaluation of antiviral activity and toxicity of recombinant human interferon alfa-2a in calves persistently infected with type 1 bovine viral diarrhea virus. Am J Vet Res 2004, 65:865-870.
183. Schneider D.S., Ayres J.S. Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat Rev Immunol 2008, 8:889-895.
184. Baigent S.J., Zhang G., Fray M.D., Flick-Smith H., Goodbourn S., McCauley J.W. Inhibition of beta interferon transcription by noncytopathogenic bovine viral diarrhea virus is through an interferon regulatory factor 3-dependent mechanism. J Virol 2002, 76:8979-8988.
185. pro. J Virol 2003, 77:7645-7654.
186. Baigent S.J., Goodbourn S., McCauley J.W. Differential activation of interferon regulatory factors-3 and -7 by non-cytopathogenic and cytopathogenic bovine viral diarrhoea virus. Vet Immunol Immunopathol 2004, 100:135-144.
187. pro. J Virol 2005, 79:7239-7247.
188. pro of classical swine fever virus is an antagonist of double-stranded RNA-mediated apoptosis and IFN-α/β induction. Virology 2005, 340:265-276.
189. pro protein is necessary for alpha/beta interferon antagonism. J Virol 2006, 80:900-911.
190. Pro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J Virol 2006, 80:11723-11732.
191. pro interacts with interferon regulatory factor 3 and induces its proteasomal degradation. J Virol 2007, 81:3087-3096.
192. pro from a cytopathic bovine viral diarrhea virus. Virology 2007, 366:277-292.
193. pro product of classical swine fever virus and bovine viral diarrhea virus uses a conserved mechanism to target interferon regulatory factor-3. J Gen Virol 2007, 88:3002-3006.
194. pro is required for interferon regulatory factor 3 interaction and degradation. J Mol Biol 2009, 391:438-449.
195. pro limits type I interferon induction in plasmacytoid dendritic cells by interacting with interferon regulatory factor 7. J Virol 2011, 85:8002-8011.
196. pro product is degraded by cellular proteasomes in a manner that does not require interaction with interferon regulatory factor 3. J Gen Virol 2010, 91:721-726.
197. pro gene. Vaccine 2004, 22:317-328.
198. pro. J Virol 2009, 83:817-829.
199. pro product of classical swine fever virus interacts with IκBα, the NF-κB inhibitor. J Gen Virol 2008, 89:1881-1889.
200. pro binds to cellular HAX-1. J Gen Virol 2010, 91:2677-2686.
201. pro of classical swine fever virus in the activation of monocyte-derived dendritic cells. Virology 2005, 343:93-105.
202. Schneider R., Unger G., Stark R., Schneider-Scherzer E., Thiel H.J. Identification of a structural glycoprotein of an RNA virus as a ribonuclease. Science 1993, 261:1169-1171.
203. Windisch J.M., Schneider R., Stark R., Weiland E., Meyers G., Thiel H.-J. RNase of classical swine fever virus: biochemical characterization and inhibition by virus-neutralizing monoclonal antibodies. J Virol 1996, 70:352-358.
204. rns is an endoribonuclease with an unusual base specificity. J Virol 2004, 78:5507-5512.
205. rns and ribotoxin L3 loop. J Biol Chem 2002, 277:5308-5314.
206. rns represents an unusual type of membrane anchor. J Virol 2005, 79:11901-11913.
207. rns is anchored in plane in the membrane via an amphipathic helix. J Biol Chem 2007, 282:32730-32741.
208. rns based on disulfide bond connectivity and homology modeling reveals an extremely rare vicinal disulfide. J Virol 2002, 76:10383-10392.
209. rns RNase prevents homodimer formation and leads to attenuation of classical swine fever virus. J Virol 2009, 83:4823-4834.
210. rns of classical swine fever virus is not essential for viral replication and infection. Arch Virol 2005, 150:2271-2286.
211. Rümenapf T., Unger G., Strauss J.H., Thiel H.-J. Processing of the envelope glycoproteins of pestiviruses. J Virol 1993, 67:3288-3294.
212. rns with cell surface glycosaminoglycans. J Gen Virol 2000, 81:451-459.
213. rns of bovine viral diarrhoea virus by site-directed mutagenesis. J Gen Virol 2002, 83:2153-2159.
214. rns of pestiviruses. J Gen Virol 2008, 89:2501-2506.
215. rns and E2 interact with different receptors. J Gen Virol 1997, 78:2779-2787.
216. Wang Z., Nie Y.C., Wang P.G., Ding M.X., Deng H.K. Characterization of classical swine fever virus entry by using pseudotyped viruses: E1 and E2 are sufficient to mediate viral entry. Virology 2004, 330:332-341.
217. rns glycoprotein in the control of activation of beta interferon by double-stranded RNA. J Virol 2004, 78:136-145.
218. rns prevents IFN type-I triggering by pestiviral single- and double-stranded RNAs. Virus Res 2009, 140:15-23.
219. Kost T.A., Condreay J.P., Jarvis D.L. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 2005, 23:567-575.
220. rns. Biochem Biophys Res Commun 2004, 319:655-662.
221. rns protein. Protein Expr Purif 2007, 55:379-387.
222. rns glycoprotein antagonizes induction of interferon-β by double-stranded RNA. Can J Microbiol 2009, 55:698-704.
223. rns glycoprotein in counteracting the Newcastle disease virus (NDV)-mediated IFN-β induction. J Biochem Mol Biol 2007, 40:611-616.
224. rns of the pestivirus classical swine fever virus lead to virus attenuation. J Virol 1999, 73:10224-10235.
225. Meyer C., Von Freyburg M., Elbers K., Meyers G. Recovery of virulent and RNase-negative attenuated type 2 bovine viral diarrhea viruses from infectious cDNA clones. J Virol 2002, 76:8494-8503.
226. Von Freyburg M., Ege A., Saalmüller A., Meyers G. Comparison of the effects of RNase-negative and wild-type classical swine fever virus on peripheral blood cells of infected pigs. J Gen Virol 2004, 85:1899-1908.
227. rns glycoprotein affects virulence in swine. Virology 2008, 370:122-129.
228. pro protease. J Virol 2007, 81:3327-3338.
229. Johns H.L., Bensaude E., La Rocca S.A., Seago J., Charleston B., Steinbach F., et al. Classical swine fever virus infection protects aortic endothelial cells from plpC-mediated apoptosis. J Gen Virol 2010, 91:1038-1046.
230. pro on virulence of bovine viral diarrhea virus and induction of interferon type I in calves. Am J Vet Res 2009, 70:1117-1123.
231. Charleston B., Fray M.D., Baigent S., Carr B.V., Morrison W.I. Establishment of persistent infection with non-cytopathic bovine viral diarrhoea virus in cattle is associated with a failure to induce type I interferon. J Gen Virol 2001, 82:1893-1897.
232. Charleston B., Brackenbury L.S., Carr B.V., Fray M.D., Hope J.C., Howard C.J., et al. Alpha/beta and gamma interferons are induced by infection with noncytopathic bovine viral diarrhea virus in vivo. J Virol 2002, 76:923-927.
233. Smirnova N.P., Bielefeldt-Ohmann H., Van Campen H., Austin K.J., Han H., Montgomery D.L., et al. Acute non-cytopathic bovine viral diarrhea virus infection induces pronounced type I interferon response in pregnant cows and fetuses. Virus Res 2008, 132:49-58.
234. Yamane D., Kato K., Tohya Y., Akashi H. The relationship between the viral RNA level and upregulation of innate immunity in spleen of cattle persistently infected with bovine viral diarrhea virus. Vet Microbiol 2008, 129:69-79.
235. Shoemaker M.L., Smirnova N.P., Bielefeldt-Ohmann H., Austin K.J., Van Olphen A., Clapper J.A., et al. Differential expression of the type I interferon pathway during persistent and transient bovine viral diarrhea virus infection. J Interferon Cytokine Res 2009, 29:23-35.
236. Brackenbury L.S., Carr B.V., Charleston B. Aspects of the innate and adaptive immune responses to acute infections with BVDV. Vet Microbiol 2003, 96:337-344.
237. Ridpath J.F. Bovine viral diarrhea virus: global status. Vet Clin North Am Food Anim Pract 2010, 26:105-121.
238. Penny R., Stuart-Harris R. Interferons: therapeutic uses. Encyclopedia of life sciences 2001, John Wiley & Sons, Ltd., Chichester. http://dx.doi:10%1361038_npg-els-0002168.
239. Pichler W.J. Adverse side-effects to biological agents. Allergy 2006, 61:912-920.
240. Biggioggero M., Gabbriellini L., Meroni P.L. Type I interferon therapy and its role in autoimmunity. Autoimmunity 2010, 43:248-254.
241. Peterhans E., Schweizer M. Pestiviruses: how to outmaneuver your hosts. Vet Microbiol 2010, 142:18-25.
242. Hüsser L., Alves M.P., Ruggli N., Summerfield A. Identification of the role of RIG-I, MDA-5 and TLR3 in sensing RNA viruses in porcine epithelial cells using lentivirus-driven RNA interference. Virus Res 2011, 159:9-16.
243. Peterhans E., Jungi T.W., Schweizer M. How the bovine viral diarrhea virus outwits the immune system. Dtsch Tierarztl Wochenschr 2006, 113:124-129.
244. Yu M., Levine S.J. Toll-like receptor 3, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses. Cytokine Growth Factor Rev 2011, 22:63-72.
245. Poeck H., Ruland J. From virus to inflammation: mechanisms of RIG-I-induced IL-1 beta production. Eur J Cell Biol 2012, 91:59-64.
246. Cooper M.A., Elliott J.M., Keyel P.A., Yang L.P., Carrero J.A., Yokoyama W.M. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A 2009, 106:1915-1919.
247. Noble A. Do we have memory of danger as well as antigen?. Trends Immunol 2009, 30:150-156.
248. Philpott D.J., Girardin S.E. Gut microbes extend reach to systemic innate immunity. Nat Med 2010, 16:160-161.
249. Netea M.G., Quintin J., Van Der Meer J.W.M. Trained immunity: a memory for innate host defense. Cell Host Microbe 2011, 9:355-361.
250. Diebold S.S. Recognition of viral single-stranded RNA by toll-like receptors. Adv Drug Deliv Rev 2008, 60:813-823.
251. Ishii K.J., Akira S. Potential link between the immune system and metabolism of nucleic acids. Curr Opin Immunol 2008, 20:524-529.
252. Mestas J., Hughes C.C.W. Of mice and not men: differences between mouse and human immunology. J Immunol 2004, 172:2731-2738.
253. Wiles S., Hanage W.P., Frankel G., Robertson B. Modelling infectious disease - time to think outside the box?. Nat Rev Microbiol 2006, 4:307-312.
254. Anonymous Life as we know it. Nature 2007, 449:1.
255. Davis M.M. A prescription for human immunology. Immunity 2008, 29:835-838.
256. Roberts R.M., Smith G.W., Bazer F.W., Cibelli J., Seidel G.E., Bauman D.E., et al. Farm animal research in crisis. Science 2009, 324:468-469.
257. Medzhitov R., Schneider D.S., Soares M.P. Disease tolerance as a defense strategy. Science 2012, 335:936-941.
258. Houe H. Epidemiology of bovine viral diarrhea virus. Vet Clin North Am Food Anim Pract 1995, 11:521-547.
259. Houe H. Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections. Vet Microbiol 1999, 64:89-107.
260. Bachofen C., Stalder H.P., Braun U., Hilbe M., Ehrensperger F., Peterhans E. Co-existence of genetically and antigenically diverse bovine viral diarrhoea viruses in an endemic situation. Vet Microbiol 2008, 131:93-102.
261. Peterhans E., Bachofen C., Stalder H.P., Schweizer M. Cytopathic bovine viral diarrhea viruses (BVDV): emerging pestiviruses doomed to extinction. Vet Res 2010, 41:44.